Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

Biocorp Production Yönetim

Yönetim kriter kontrolleri 1/4

Şu anda CEO hakkında yeterli bilgiye sahip değiliz.

Anahtar bilgiler

Eric Dessertenne

İcra Kurulu Başkanı

n/a

Toplam tazminat

CEO maaş yüzdesi	n/a
CEO görev süresi	3.8yrs
CEO sahipliği	n/a
Yönetim ortalama görev süresi	Veri yok
Yönetim Kurulu ortalama görev süresi	8.4yrs

Son yönetim güncellemeleri

Recent updates

Would Biocorp Production (EPA:ALCOR) Be Better Off With Less Debt?

Dec 08

What Does The Future Hold For Biocorp Production (EPA:ALCOR)? These Analysts Have Been Cutting Their Estimates

Jun 26

Biocorp Production (EPA:ALCOR) Just Reported And Analysts Have Been Cutting Their Estimates

Apr 11

What Type Of Shareholders Own The Most Number of Biocorp Production (EPA:ALCOR) Shares?

Mar 04

Is Biocorp Production's (EPA:ALCOR) Share Price Gain Of 179% Well Earned?

Jan 10

What Type Of Shareholders Own The Most Number of Biocorp Production (EPA:ALCOR) Shares?

Nov 18

CEO

Eric Dessertenne

3.8yrs

Görev süresi

Mr. Eric Dessertenne has been Chief Executive Officer at Biocorp Production since December 23, 2019 and its Director since September 24, 2021. He had been Chief Operating Officer of Biocorp Production sinc...

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Eric Dessertenne	CEO & Director	2.1yrs	Veri yok	Veri yok
Jean-Yves Berthon	Independent Director	8.4yrs	Veri yok	Veri yok
Lutz Heinemann	Member of Scientific Advisory Board	no data	Veri yok	Veri yok
Stephane Legastelois	Independent Director	8.4yrs	Veri yok	Veri yok
Julien Gardette	Director	8.4yrs	Veri yok	Veri yok
Jean-Pierre Riveline	Member of Scientific Advisory Board	no data	Veri yok	Veri yok
Pauline Schaepelynck-Belicar	Member of Scientific Advisory Board	no data	Veri yok	Veri yok
Novo Nordisk	Chairman of the Board	no data	Veri yok	Veri yok

8.4yrs

Ortalama Görev Süresi

Deneyimli Yönetim Kurulu: ALCOR 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 8.4 yıldır).

Biocorp Production Yönetim

Yönetim kriter kontrolleri 1/4

Anahtar bilgiler

Son yönetim güncellemeleri

Less than half of directors are independent

Less than half of directors are independent

Recent updates

First half 2023 earnings released: €0.86 loss per share (vs €0.53 loss in 1H 2022)

Novo Nordisk A/S (CPSE:NOVO B) agreed to acquire a 64.4% stake in Biocorp Production (ENXTPA:ALCOR) for €99.1 million.

Novo Nordisk Enters into Exclusive Negotiations to Acquire A Controlling Stake in Bicorp, to Be Followed by A Tender Offer on All Remaining Shares

Full year 2022 earnings released

Biocorp Production to Report First Half, 2023 Results on Sep 28, 2023

Biocorp Production announced that it has received €2.5 million in funding from Vatel Capital SAS

Would Biocorp Production (EPA:ALCOR) Be Better Off With Less Debt?

Biocorp Production Obtains 510(K) FDA Clearance for Mallya

Less than half of directors are independent

First half 2022 earnings released: EPS: €0 (vs €0.28 loss in 1H 2021)

Consensus EPS estimates increase by 38%

What Does The Future Hold For Biocorp Production (EPA:ALCOR)? These Analysts Have Been Cutting Their Estimates

Consensus forecasts updated

Price target increased to €36.53

Less than half of directors are independent

Full year 2021 earnings: Revenues miss analyst expectations

First half 2021 earnings released

Biocorp Production (EPA:ALCOR) Just Reported And Analysts Have Been Cutting Their Estimates

Full year 2020 earnings released

New 90-day high: €30.60

What Type Of Shareholders Own The Most Number of Biocorp Production (EPA:ALCOR) Shares?

BIOCORP Announces the Signature of New Partnerships with Health2sync and SocialDiabetes

New 90-day high: €30.40

Is Biocorp Production's (EPA:ALCOR) Share Price Gain Of 179% Well Earned?

Biocorp Production to Report Fiscal Year 2020 Results on Apr 08, 2021

What Type Of Shareholders Own The Most Number of Biocorp Production (EPA:ALCOR) Shares?

BIOCORP Announces Launch of Mallya

New 90-day high: €33.00

Biocorp Production Announces Partnership with AARDEX Group to Extend Smart Solutions for Precision Medication Adherence

New 90-day high - €28.50

CEO

Görev süresi

Yönetim Kurulu Üyeleri

Ortalama Görev Süresi